Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2021 Apr;24(3):507-511.
doi: 10.1111/ner.13280. Epub 2020 Oct 5.

Explantation Rates of High Frequency Spinal Cord Stimulation in Two Outpatient Clinics

Victor C Wang  1 , Vickie Bounkousohn  1 , Kara Fields  1 , Clifford Bernstein  1 , Richard M Paicius  1 , Christopher Gilligan  1
Affiliations
Randomized Controlled Trial

Explantation Rates of High Frequency Spinal Cord Stimulation in Two Outpatient Clinics

Victor C Wang et al. Neuromodulation. 2021 Apr.

Erratum in

Abstract

Objectives: To report the explantation rates of high frequency 10 kHz spinal cord stimulation (SCS) in a real-world setting.

Materials and methods: This is a retrospective review of patients implanted with high frequency spinal cord stimulators over a 4-year period in two outpatient private practice clinics, from July 2015 through June 2019, using the Kaplan-Meier product-limit method to estimate probabilities of implant survival over time.

Results: The estimated median time to explantation was 3.5 years (95% confidence interval [CI] = 3.1-3.7) [Correction added on 15 October 2020, after first online publication: The preceeding sentence was amended to reflect the estimated median time.]. The estimated probabilities of implant survival beyond 1, 2, and 3 years postimplantation were 88.4% (95% CI = 81.3-93.0%), 76.5% (95% CI = 67.8-83.2%), and 60.7% (95% CI = 50.2-69.6%), respectively. The minimum (i.e., known) cumulative percentages of patients explanted by 1, 2, and 3 years postimplantation were 11.1% (14/126), 22.2% (28/126), and 32.5% (41/126), respectively. 65.9% of patients in this study had prior neurostimulation.

Conclusions: Recently, high frequency SCS technology has been demonstrated as more effective in treatment of lower- and leg-pain, compared to conventional low frequency SCS, in a 12-month randomized controlled trial (SENZA-RCT). Longer term results have yet to be published. In this study, we found that the explantation rate was much higher than expected, based on the prior studies demonstrating its efficacy. As the use of neuromodulation continues to grow, longitudinal data will be critical in understanding its long-term effects on treated patients.

Keywords: Chronic pain; SCS; explantation; high frequency electrical stimulation; neurostimulation.

PubMed Disclaimer

References

REFERENCES

    1. Hayek SM, Veizi E, Hanes M. Treatment-limiting complications of percutaneous spinal cord stimulator implants: a review of eight years of experience from an academic center database. Neuromodulation 2015;18:603-609.
    1. Shealy CN, Mortimer JT, Reswick JB. Electrical inhibition of pain by stimulation of the dorsal columns: preliminary clinical report. Anesth Analg 1967;46:489-491.
    1. Pope JE, Deer TR, Falowski S et al. Multicenter retrospective study of neurostimulation with exit of therapy by explant. Neuromodulation 2017;20:543-552.
    1. Pollard EM, Lamer TJ, Moeschler SM et al. The effect of spinal cord stimulation on pain medication reduction in intractable spine and limb pain: a systematic review of randomized controlled trials and meta-analysis. J Pain Res 2019;12:1311-1324.
    1. Sharan AD, Riley J, Falowski S et al. Association of opioid usage with spinal cord stimulation outcomes. Pain Med 2018;19:699-707.

Publication types

LinkOut - more resources